Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Cancer Medicine|March 19, 2026
Early Mycophenolate Mofetil Combination Therapy as an Effective Approach for Immune-Related Hepatitis Induced by Immune Checkpoint Inhibitors in Patients With Solid TumorYukiko Shimoda Igawa, Tatsuya Yoshida, Jun Sato, et al.
Scientific Reports|July 3, 2023
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapySho Watanabe, Tatsunori Shimoi, Tadaaki Nishikawa, et al.
Oncology|September 21, 2013
Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillanceRoopma Wadhwa, Takashi Taketa, Arlene M Correa, et al.
Anticancer Research|April 27, 2024
Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker AnalysisToru Imai, Yuki Kojima, Tatsunori Shimoi, et al.
Oncology|July 18, 2013
Propensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiationTakashi Taketa, Lianchun Xiao, Kazuki Sudo, et al.
Gynecologic Oncology Reports|December 6, 2023
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinomaYuki Kojima, Hiroshi Yoshida, Toshihiro Okuya, et al.
Oncology|July 11, 2015
Early versus Delayed Therapy of Advanced Gastric Cancer Patients--Does It Make a Difference?Elena Elimova, Hironori Shiozaki, Rebecca S Slack, et al.
Oncology|March 14, 2015
Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinomaHironori Shiozaki, Rebecca Slack, Kazuki Sudo, et al.
Breast Cancer Research and Treatment|November 17, 2022
Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapyShu Yazaki, Tatsunori Shimoi, Masayuki Yoshida, et al.
Japanese Journal of Clinical Oncology|January 30, 2026
A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110)Keita Sasaki, Toshiyuki Ishiba, Ikuno Nishibuchi, et al.
Pageof 14